DepoCyt® (cytarabine liposome injection) is supplied as a sterile, white to off-white suspension in 5 mL glass, single use vials. Refrigerate at 2° to 8°C (36° to 46°F). Protect from freezing and avoid aggressive agitation. Available as individual carton containing one ready to use vial. NDC 57665-331-01. Do not use beyond expiration date printed on the label. For additional information, contact Sigma-Tau Pharmaceuticals, Inc., at: 866-792-5172 REFERENCES 1. NIOSH Alert: Preventing occupational exposures to antineoplastic and other hazardous drugs in healthcare settings. 2004. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 200 165. 2. OSHA Technical Manual, TED 1-0.15A, Section VI: Chapter 2. Controlling Occupational Exposure to Hazardous Drugs. OSHA, 1999. http://www.osha.gov/dts/osta/otm/otm_vi/otm_vi_2.html 3. NIH . 1999 recommendations for the safe handling of cytotoxic drugs. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, NIH Publication No. 92- 2621. 4. American Society of Health-System Pharmacists. (2006) ASHP Guidelines on Handling Hazardous Drugs. 5. Polovich, M., White, J. M., & Kelleher, L.O. (eds.) 2005. Chemotherapy and biotherapy guidelines and recommendations for practice (2nd. ed.) Pittsburgh, PA: Oncology Nursing Society. Manufactured by: Pacira Pharmaceuticals Inc. San Diego, CA 92121. Distributed by: Sigma-Tau Pharmaceuticals, Inc. Gaithersburg, MD 20878. January 2011Last reviewed on RxList: 8/19/2011
This monograph has been modified to include the generic and brand name in many instances.